nodes	percent_of_prediction	percent_of_DWPC	metapath
Idarubicin—Epirubicin—sarcoma	0.146	0.519	CrCtD
Idarubicin—Doxorubicin—sarcoma	0.135	0.481	CrCtD
Idarubicin—Anthracyclines—Epirubicin—sarcoma	0.0803	0.215	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.0777	0.208	CiPCiCtD
Idarubicin—Anthracyclines—Doxorubicin—sarcoma	0.0743	0.199	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Etoposide—sarcoma	0.061	0.163	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.042	0.112	CiPCiCtD
Idarubicin—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.0388	0.104	CiPCiCtD
Idarubicin—Daunorubicin—Epirubicin—sarcoma	0.0311	0.173	CrCrCtD
Idarubicin—Doxorubicin—Epirubicin—sarcoma	0.0311	0.173	CrCrCtD
Idarubicin—Valrubicin—Epirubicin—sarcoma	0.0311	0.173	CrCrCtD
Idarubicin—Valrubicin—Doxorubicin—sarcoma	0.0288	0.16	CrCrCtD
Idarubicin—Daunorubicin—Doxorubicin—sarcoma	0.0288	0.16	CrCrCtD
Idarubicin—Epirubicin—Doxorubicin—sarcoma	0.0288	0.16	CrCrCtD
Idarubicin—TOP2A—Mitoxantrone—sarcoma	0.0236	0.181	CbGbCtD
Idarubicin—TOP2A—Epirubicin—sarcoma	0.0191	0.147	CbGbCtD
Idarubicin—TOP2A—Etoposide—sarcoma	0.0149	0.114	CbGbCtD
Idarubicin—ABCC1—Dactinomycin—sarcoma	0.0146	0.112	CbGbCtD
Idarubicin—ABCC1—Mitoxantrone—sarcoma	0.0131	0.1	CbGbCtD
Idarubicin—ABCC1—Epirubicin—sarcoma	0.0106	0.0813	CbGbCtD
Idarubicin—TOP2A—Doxorubicin—sarcoma	0.0101	0.078	CbGbCtD
Idarubicin—ABCC1—Vincristine—sarcoma	0.00898	0.0691	CbGbCtD
Idarubicin—ABCC1—Etoposide—sarcoma	0.00823	0.0634	CbGbCtD
Idarubicin—ABCC1—Doxorubicin—sarcoma	0.00562	0.0432	CbGbCtD
Idarubicin—CYP2D6—Doxorubicin—sarcoma	0.00128	0.00983	CbGbCtD
Idarubicin—TOP2A—Vindesine—Vincristine—sarcoma	0.000154	0.218	CbGdCrCtD
Idarubicin—TOP2A—Vinorelbine—Vincristine—sarcoma	9.73e-05	0.137	CbGdCrCtD
Idarubicin—TOP2A—Podofilox—Etoposide—sarcoma	9.73e-05	0.137	CbGdCrCtD
Idarubicin—TOP2A—Teniposide—Etoposide—sarcoma	9.73e-05	0.137	CbGdCrCtD
Idarubicin—TOP2A—Vinblastine—Vincristine—sarcoma	6.69e-05	0.0945	CbGdCrCtD
Idarubicin—Stomatitis—Dactinomycin—sarcoma	6.18e-05	0.00177	CcSEcCtD
Idarubicin—Burning sensation—Doxorubicin—sarcoma	6.12e-05	0.00175	CcSEcCtD
Idarubicin—Pancytopenia—Vincristine—sarcoma	6.03e-05	0.00173	CcSEcCtD
Idarubicin—Neutropenia—Vincristine—sarcoma	5.94e-05	0.0017	CcSEcCtD
Idarubicin—Pancytopenia—Mitoxantrone—sarcoma	5.87e-05	0.00168	CcSEcCtD
Idarubicin—Necrosis—Epirubicin—sarcoma	5.86e-05	0.00168	CcSEcCtD
Idarubicin—Neutropenia—Mitoxantrone—sarcoma	5.78e-05	0.00166	CcSEcCtD
Idarubicin—Haemoglobin—Thiotepa—sarcoma	5.76e-05	0.00165	CcSEcCtD
Idarubicin—Haemorrhage—Thiotepa—sarcoma	5.73e-05	0.00164	CcSEcCtD
Idarubicin—Urinary tract disorder—Thiotepa—sarcoma	5.66e-05	0.00162	CcSEcCtD
Idarubicin—Urethral disorder—Thiotepa—sarcoma	5.62e-05	0.00161	CcSEcCtD
Idarubicin—Acute coronary syndrome—Vincristine—sarcoma	5.58e-05	0.0016	CcSEcCtD
Idarubicin—Myocardial infarction—Vincristine—sarcoma	5.55e-05	0.00159	CcSEcCtD
Idarubicin—Stomatitis—Vincristine—sarcoma	5.52e-05	0.00158	CcSEcCtD
Idarubicin—Acute coronary syndrome—Mitoxantrone—sarcoma	5.44e-05	0.00156	CcSEcCtD
Idarubicin—Necrosis—Doxorubicin—sarcoma	5.42e-05	0.00155	CcSEcCtD
Idarubicin—Myocardial infarction—Mitoxantrone—sarcoma	5.41e-05	0.00155	CcSEcCtD
Idarubicin—Stomatitis—Mitoxantrone—sarcoma	5.38e-05	0.00154	CcSEcCtD
Idarubicin—Flushing—Dactinomycin—sarcoma	5.28e-05	0.00151	CcSEcCtD
Idarubicin—Extravasation—Epirubicin—sarcoma	5.27e-05	0.00151	CcSEcCtD
Idarubicin—Angiopathy—Thiotepa—sarcoma	5.2e-05	0.00149	CcSEcCtD
Idarubicin—Immune system disorder—Thiotepa—sarcoma	5.18e-05	0.00148	CcSEcCtD
Idarubicin—Chills—Thiotepa—sarcoma	5.14e-05	0.00147	CcSEcCtD
Idarubicin—Arrhythmia—Thiotepa—sarcoma	5.12e-05	0.00147	CcSEcCtD
Idarubicin—Chills—Dactinomycin—sarcoma	5.1e-05	0.00146	CcSEcCtD
Idarubicin—TOP2A—Doxorubicin—Epirubicin—sarcoma	5.07e-05	0.0716	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Epirubicin—sarcoma	5.07e-05	0.0716	CbGdCrCtD
Idarubicin—Alopecia—Thiotepa—sarcoma	5.07e-05	0.00145	CcSEcCtD
Idarubicin—Alopecia—Dactinomycin—sarcoma	5.03e-05	0.00144	CcSEcCtD
Idarubicin—Urinary tract disorder—Vincristine—sarcoma	5.02e-05	0.00144	CcSEcCtD
Idarubicin—Malnutrition—Thiotepa—sarcoma	4.99e-05	0.00143	CcSEcCtD
Idarubicin—Urethral disorder—Vincristine—sarcoma	4.98e-05	0.00143	CcSEcCtD
Idarubicin—Haemoglobin—Mitoxantrone—sarcoma	4.98e-05	0.00142	CcSEcCtD
Idarubicin—Hyperuricaemia—Epirubicin—sarcoma	4.95e-05	0.00142	CcSEcCtD
Idarubicin—Haemorrhage—Mitoxantrone—sarcoma	4.95e-05	0.00142	CcSEcCtD
Idarubicin—Pancytopenia—Etoposide—sarcoma	4.89e-05	0.0014	CcSEcCtD
Idarubicin—Extravasation—Doxorubicin—sarcoma	4.87e-05	0.0014	CcSEcCtD
Idarubicin—Ulcer—Epirubicin—sarcoma	4.86e-05	0.00139	CcSEcCtD
Idarubicin—Neutropenia—Etoposide—sarcoma	4.81e-05	0.00138	CcSEcCtD
Idarubicin—Atrioventricular block—Epirubicin—sarcoma	4.74e-05	0.00136	CcSEcCtD
Idarubicin—TOP2A—Epirubicin—Doxorubicin—sarcoma	4.69e-05	0.0662	CbGdCrCtD
Idarubicin—TOP2A—Daunorubicin—Doxorubicin—sarcoma	4.69e-05	0.0662	CbGdCrCtD
Idarubicin—Blood uric acid increased—Epirubicin—sarcoma	4.68e-05	0.00134	CcSEcCtD
Idarubicin—Anaemia—Thiotepa—sarcoma	4.61e-05	0.00132	CcSEcCtD
Idarubicin—Angiopathy—Vincristine—sarcoma	4.61e-05	0.00132	CcSEcCtD
Idarubicin—Hyperuricaemia—Doxorubicin—sarcoma	4.58e-05	0.00131	CcSEcCtD
Idarubicin—Anaemia—Dactinomycin—sarcoma	4.58e-05	0.00131	CcSEcCtD
Idarubicin—Acute coronary syndrome—Etoposide—sarcoma	4.52e-05	0.00129	CcSEcCtD
Idarubicin—Ulcer—Doxorubicin—sarcoma	4.5e-05	0.00129	CcSEcCtD
Idarubicin—Myocardial infarction—Etoposide—sarcoma	4.5e-05	0.00129	CcSEcCtD
Idarubicin—Alopecia—Vincristine—sarcoma	4.49e-05	0.00129	CcSEcCtD
Idarubicin—Stomatitis—Etoposide—sarcoma	4.47e-05	0.00128	CcSEcCtD
Idarubicin—Leukopenia—Thiotepa—sarcoma	4.47e-05	0.00128	CcSEcCtD
Idarubicin—Chills—Mitoxantrone—sarcoma	4.44e-05	0.00127	CcSEcCtD
Idarubicin—Leukopenia—Dactinomycin—sarcoma	4.43e-05	0.00127	CcSEcCtD
Idarubicin—Arrhythmia—Mitoxantrone—sarcoma	4.42e-05	0.00127	CcSEcCtD
Idarubicin—Colitis—Epirubicin—sarcoma	4.41e-05	0.00126	CcSEcCtD
Idarubicin—Atrioventricular block—Doxorubicin—sarcoma	4.38e-05	0.00126	CcSEcCtD
Idarubicin—Alopecia—Mitoxantrone—sarcoma	4.37e-05	0.00125	CcSEcCtD
Idarubicin—Blood uric acid increased—Doxorubicin—sarcoma	4.33e-05	0.00124	CcSEcCtD
Idarubicin—Convulsion—Thiotepa—sarcoma	4.32e-05	0.00124	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	4.22e-05	0.00121	CcSEcCtD
Idarubicin—Oesophagitis—Epirubicin—sarcoma	4.2e-05	0.0012	CcSEcCtD
Idarubicin—Neoplasm—Epirubicin—sarcoma	4.16e-05	0.00119	CcSEcCtD
Idarubicin—Anaemia—Vincristine—sarcoma	4.09e-05	0.00117	CcSEcCtD
Idarubicin—Colitis—Doxorubicin—sarcoma	4.08e-05	0.00117	CcSEcCtD
Idarubicin—Urinary tract disorder—Etoposide—sarcoma	4.07e-05	0.00116	CcSEcCtD
Idarubicin—Infection—Thiotepa—sarcoma	4.05e-05	0.00116	CcSEcCtD
Idarubicin—Urethral disorder—Etoposide—sarcoma	4.04e-05	0.00116	CcSEcCtD
Idarubicin—Infection—Dactinomycin—sarcoma	4.02e-05	0.00115	CcSEcCtD
Idarubicin—Sepsis—Epirubicin—sarcoma	3.99e-05	0.00114	CcSEcCtD
Idarubicin—Thrombocytopenia—Thiotepa—sarcoma	3.99e-05	0.00114	CcSEcCtD
Idarubicin—Anaemia—Mitoxantrone—sarcoma	3.98e-05	0.00114	CcSEcCtD
Idarubicin—Leukopenia—Vincristine—sarcoma	3.96e-05	0.00113	CcSEcCtD
Idarubicin—Thrombocytopenia—Dactinomycin—sarcoma	3.96e-05	0.00113	CcSEcCtD
Idarubicin—Skin disorder—Thiotepa—sarcoma	3.96e-05	0.00113	CcSEcCtD
Idarubicin—Oesophagitis—Doxorubicin—sarcoma	3.89e-05	0.00111	CcSEcCtD
Idarubicin—Anorexia—Thiotepa—sarcoma	3.88e-05	0.00111	CcSEcCtD
Idarubicin—Phlebitis—Epirubicin—sarcoma	3.87e-05	0.00111	CcSEcCtD
Idarubicin—Leukopenia—Mitoxantrone—sarcoma	3.86e-05	0.0011	CcSEcCtD
Idarubicin—Thrombophlebitis—Epirubicin—sarcoma	3.85e-05	0.0011	CcSEcCtD
Idarubicin—Anorexia—Dactinomycin—sarcoma	3.85e-05	0.0011	CcSEcCtD
Idarubicin—Neoplasm—Doxorubicin—sarcoma	3.85e-05	0.0011	CcSEcCtD
Idarubicin—Convulsion—Vincristine—sarcoma	3.83e-05	0.0011	CcSEcCtD
Idarubicin—Flushing—Etoposide—sarcoma	3.82e-05	0.00109	CcSEcCtD
Idarubicin—Hepatic function abnormal—Epirubicin—sarcoma	3.82e-05	0.00109	CcSEcCtD
Idarubicin—Angiopathy—Etoposide—sarcoma	3.74e-05	0.00107	CcSEcCtD
Idarubicin—Convulsion—Mitoxantrone—sarcoma	3.73e-05	0.00107	CcSEcCtD
Idarubicin—Immune system disorder—Etoposide—sarcoma	3.72e-05	0.00107	CcSEcCtD
Idarubicin—Chills—Etoposide—sarcoma	3.69e-05	0.00106	CcSEcCtD
Idarubicin—Sepsis—Doxorubicin—sarcoma	3.69e-05	0.00106	CcSEcCtD
Idarubicin—Cardiac failure congestive—Epirubicin—sarcoma	3.68e-05	0.00105	CcSEcCtD
Idarubicin—Chest pain—Mitoxantrone—sarcoma	3.67e-05	0.00105	CcSEcCtD
Idarubicin—Alopecia—Etoposide—sarcoma	3.64e-05	0.00104	CcSEcCtD
Idarubicin—Anaphylactic shock—Vincristine—sarcoma	3.61e-05	0.00103	CcSEcCtD
Idarubicin—Infection—Vincristine—sarcoma	3.59e-05	0.00103	CcSEcCtD
Idarubicin—Phlebitis—Doxorubicin—sarcoma	3.58e-05	0.00103	CcSEcCtD
Idarubicin—Hot flush—Epirubicin—sarcoma	3.57e-05	0.00102	CcSEcCtD
Idarubicin—Thrombophlebitis—Doxorubicin—sarcoma	3.57e-05	0.00102	CcSEcCtD
Idarubicin—Decreased appetite—Thiotepa—sarcoma	3.54e-05	0.00101	CcSEcCtD
Idarubicin—Menopausal symptoms—Epirubicin—sarcoma	3.54e-05	0.00101	CcSEcCtD
Idarubicin—Thrombocytopenia—Vincristine—sarcoma	3.54e-05	0.00101	CcSEcCtD
Idarubicin—Hepatic function abnormal—Doxorubicin—sarcoma	3.53e-05	0.00101	CcSEcCtD
Idarubicin—Anaphylactic shock—Mitoxantrone—sarcoma	3.52e-05	0.00101	CcSEcCtD
Idarubicin—Decreased appetite—Dactinomycin—sarcoma	3.51e-05	0.00101	CcSEcCtD
Idarubicin—Infection—Mitoxantrone—sarcoma	3.49e-05	0.001	CcSEcCtD
Idarubicin—Shock—Mitoxantrone—sarcoma	3.46e-05	0.000991	CcSEcCtD
Idarubicin—Thrombocytopenia—Mitoxantrone—sarcoma	3.44e-05	0.000986	CcSEcCtD
Idarubicin—Anorexia—Vincristine—sarcoma	3.44e-05	0.000986	CcSEcCtD
Idarubicin—Skin disorder—Mitoxantrone—sarcoma	3.42e-05	0.000978	CcSEcCtD
Idarubicin—Cardiac failure congestive—Doxorubicin—sarcoma	3.4e-05	0.000975	CcSEcCtD
Idarubicin—Anorexia—Mitoxantrone—sarcoma	3.35e-05	0.00096	CcSEcCtD
Idarubicin—Gastrointestinal pain—Thiotepa—sarcoma	3.33e-05	0.000954	CcSEcCtD
Idarubicin—Anaemia—Etoposide—sarcoma	3.31e-05	0.000949	CcSEcCtD
Idarubicin—Gastrointestinal pain—Dactinomycin—sarcoma	3.31e-05	0.000946	CcSEcCtD
Idarubicin—Hot flush—Doxorubicin—sarcoma	3.3e-05	0.000945	CcSEcCtD
Idarubicin—Menopausal symptoms—Doxorubicin—sarcoma	3.27e-05	0.000937	CcSEcCtD
Idarubicin—Urticaria—Thiotepa—sarcoma	3.24e-05	0.000926	CcSEcCtD
Idarubicin—Body temperature increased—Thiotepa—sarcoma	3.22e-05	0.000922	CcSEcCtD
Idarubicin—Abdominal pain—Thiotepa—sarcoma	3.22e-05	0.000922	CcSEcCtD
Idarubicin—Leukopenia—Etoposide—sarcoma	3.21e-05	0.000919	CcSEcCtD
Idarubicin—Body temperature increased—Dactinomycin—sarcoma	3.2e-05	0.000915	CcSEcCtD
Idarubicin—Abdominal pain—Dactinomycin—sarcoma	3.2e-05	0.000915	CcSEcCtD
Idarubicin—Decreased appetite—Vincristine—sarcoma	3.14e-05	0.000899	CcSEcCtD
Idarubicin—Convulsion—Etoposide—sarcoma	3.11e-05	0.000889	CcSEcCtD
Idarubicin—Dehydration—Epirubicin—sarcoma	3.1e-05	0.000889	CcSEcCtD
Idarubicin—Decreased appetite—Mitoxantrone—sarcoma	3.06e-05	0.000875	CcSEcCtD
Idarubicin—Chest pain—Etoposide—sarcoma	3.05e-05	0.000874	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	3.03e-05	0.000868	CcSEcCtD
Idarubicin—Hypersensitivity—Thiotepa—sarcoma	3e-05	0.000859	CcSEcCtD
Idarubicin—Hypersensitivity—Dactinomycin—sarcoma	2.98e-05	0.000853	CcSEcCtD
Idarubicin—Gastrointestinal pain—Vincristine—sarcoma	2.95e-05	0.000846	CcSEcCtD
Idarubicin—Anaphylactic shock—Etoposide—sarcoma	2.93e-05	0.000838	CcSEcCtD
Idarubicin—Infection—Etoposide—sarcoma	2.91e-05	0.000832	CcSEcCtD
Idarubicin—Gastrointestinal pain—Mitoxantrone—sarcoma	2.88e-05	0.000824	CcSEcCtD
Idarubicin—Dehydration—Doxorubicin—sarcoma	2.87e-05	0.000822	CcSEcCtD
Idarubicin—Thrombocytopenia—Etoposide—sarcoma	2.86e-05	0.00082	CcSEcCtD
Idarubicin—Abdominal pain—Vincristine—sarcoma	2.85e-05	0.000818	CcSEcCtD
Idarubicin—Body temperature increased—Vincristine—sarcoma	2.85e-05	0.000818	CcSEcCtD
Idarubicin—Skin disorder—Etoposide—sarcoma	2.84e-05	0.000814	CcSEcCtD
Idarubicin—Urticaria—Mitoxantrone—sarcoma	2.79e-05	0.0008	CcSEcCtD
Idarubicin—Anorexia—Etoposide—sarcoma	2.79e-05	0.000799	CcSEcCtD
Idarubicin—Diarrhoea—Thiotepa—sarcoma	2.79e-05	0.000798	CcSEcCtD
Idarubicin—Body temperature increased—Mitoxantrone—sarcoma	2.78e-05	0.000796	CcSEcCtD
Idarubicin—Abdominal pain—Mitoxantrone—sarcoma	2.78e-05	0.000796	CcSEcCtD
Idarubicin—Diarrhoea—Dactinomycin—sarcoma	2.77e-05	0.000792	CcSEcCtD
Idarubicin—Pancytopenia—Epirubicin—sarcoma	2.74e-05	0.000784	CcSEcCtD
Idarubicin—Neutropenia—Epirubicin—sarcoma	2.7e-05	0.000772	CcSEcCtD
Idarubicin—Hypersensitivity—Vincristine—sarcoma	2.66e-05	0.000762	CcSEcCtD
Idarubicin—Hypersensitivity—Mitoxantrone—sarcoma	2.59e-05	0.000742	CcSEcCtD
Idarubicin—Vomiting—Thiotepa—sarcoma	2.59e-05	0.000742	CcSEcCtD
Idarubicin—Vomiting—Dactinomycin—sarcoma	2.57e-05	0.000736	CcSEcCtD
Idarubicin—Rash—Thiotepa—sarcoma	2.57e-05	0.000735	CcSEcCtD
Idarubicin—Dermatitis—Thiotepa—sarcoma	2.57e-05	0.000735	CcSEcCtD
Idarubicin—Headache—Thiotepa—sarcoma	2.55e-05	0.000731	CcSEcCtD
Idarubicin—Rash—Dactinomycin—sarcoma	2.55e-05	0.00073	CcSEcCtD
Idarubicin—Decreased appetite—Etoposide—sarcoma	2.54e-05	0.000728	CcSEcCtD
Idarubicin—Pancytopenia—Doxorubicin—sarcoma	2.53e-05	0.000726	CcSEcCtD
Idarubicin—Stomatitis—Epirubicin—sarcoma	2.51e-05	0.000718	CcSEcCtD
Idarubicin—Neutropenia—Doxorubicin—sarcoma	2.49e-05	0.000714	CcSEcCtD
Idarubicin—Diarrhoea—Vincristine—sarcoma	2.47e-05	0.000708	CcSEcCtD
Idarubicin—Nausea—Thiotepa—sarcoma	2.42e-05	0.000693	CcSEcCtD
Idarubicin—Diarrhoea—Mitoxantrone—sarcoma	2.41e-05	0.000689	CcSEcCtD
Idarubicin—Nausea—Dactinomycin—sarcoma	2.4e-05	0.000688	CcSEcCtD
Idarubicin—Gastrointestinal pain—Etoposide—sarcoma	2.39e-05	0.000685	CcSEcCtD
Idarubicin—Urticaria—Etoposide—sarcoma	2.32e-05	0.000666	CcSEcCtD
Idarubicin—Haemoglobin—Epirubicin—sarcoma	2.32e-05	0.000664	CcSEcCtD
Idarubicin—Stomatitis—Doxorubicin—sarcoma	2.32e-05	0.000664	CcSEcCtD
Idarubicin—Abdominal pain—Etoposide—sarcoma	2.31e-05	0.000662	CcSEcCtD
Idarubicin—Body temperature increased—Etoposide—sarcoma	2.31e-05	0.000662	CcSEcCtD
Idarubicin—Haemorrhage—Epirubicin—sarcoma	2.31e-05	0.000661	CcSEcCtD
Idarubicin—Vomiting—Vincristine—sarcoma	2.3e-05	0.000658	CcSEcCtD
Idarubicin—Urinary tract disorder—Epirubicin—sarcoma	2.28e-05	0.000653	CcSEcCtD
Idarubicin—Rash—Vincristine—sarcoma	2.28e-05	0.000652	CcSEcCtD
Idarubicin—Dermatitis—Vincristine—sarcoma	2.27e-05	0.000651	CcSEcCtD
Idarubicin—Urethral disorder—Epirubicin—sarcoma	2.26e-05	0.000648	CcSEcCtD
Idarubicin—Headache—Vincristine—sarcoma	2.26e-05	0.000648	CcSEcCtD
Idarubicin—Vomiting—Mitoxantrone—sarcoma	2.24e-05	0.00064	CcSEcCtD
Idarubicin—Rash—Mitoxantrone—sarcoma	2.22e-05	0.000635	CcSEcCtD
Idarubicin—Dermatitis—Mitoxantrone—sarcoma	2.22e-05	0.000634	CcSEcCtD
Idarubicin—Headache—Mitoxantrone—sarcoma	2.2e-05	0.000631	CcSEcCtD
Idarubicin—Hypersensitivity—Etoposide—sarcoma	2.16e-05	0.000617	CcSEcCtD
Idarubicin—Haemoglobin—Doxorubicin—sarcoma	2.15e-05	0.000615	CcSEcCtD
Idarubicin—Nausea—Vincristine—sarcoma	2.15e-05	0.000614	CcSEcCtD
Idarubicin—Flushing—Epirubicin—sarcoma	2.14e-05	0.000613	CcSEcCtD
Idarubicin—Haemorrhage—Doxorubicin—sarcoma	2.14e-05	0.000612	CcSEcCtD
Idarubicin—Urinary tract disorder—Doxorubicin—sarcoma	2.11e-05	0.000604	CcSEcCtD
Idarubicin—Angiopathy—Epirubicin—sarcoma	2.09e-05	0.0006	CcSEcCtD
Idarubicin—Urethral disorder—Doxorubicin—sarcoma	2.09e-05	0.000599	CcSEcCtD
Idarubicin—Nausea—Mitoxantrone—sarcoma	2.09e-05	0.000598	CcSEcCtD
Idarubicin—Immune system disorder—Epirubicin—sarcoma	2.08e-05	0.000597	CcSEcCtD
Idarubicin—Chills—Epirubicin—sarcoma	2.07e-05	0.000593	CcSEcCtD
Idarubicin—Arrhythmia—Epirubicin—sarcoma	2.06e-05	0.00059	CcSEcCtD
Idarubicin—Alopecia—Epirubicin—sarcoma	2.04e-05	0.000584	CcSEcCtD
Idarubicin—Malnutrition—Epirubicin—sarcoma	2.01e-05	0.000575	CcSEcCtD
Idarubicin—Diarrhoea—Etoposide—sarcoma	2e-05	0.000573	CcSEcCtD
Idarubicin—Flushing—Doxorubicin—sarcoma	1.98e-05	0.000568	CcSEcCtD
Idarubicin—Angiopathy—Doxorubicin—sarcoma	1.94e-05	0.000555	CcSEcCtD
Idarubicin—Immune system disorder—Doxorubicin—sarcoma	1.93e-05	0.000552	CcSEcCtD
Idarubicin—Chills—Doxorubicin—sarcoma	1.92e-05	0.000549	CcSEcCtD
Idarubicin—Arrhythmia—Doxorubicin—sarcoma	1.91e-05	0.000546	CcSEcCtD
Idarubicin—Alopecia—Doxorubicin—sarcoma	1.89e-05	0.00054	CcSEcCtD
Idarubicin—Vomiting—Etoposide—sarcoma	1.86e-05	0.000533	CcSEcCtD
Idarubicin—Malnutrition—Doxorubicin—sarcoma	1.86e-05	0.000532	CcSEcCtD
Idarubicin—Anaemia—Epirubicin—sarcoma	1.86e-05	0.000532	CcSEcCtD
Idarubicin—Rash—Etoposide—sarcoma	1.84e-05	0.000528	CcSEcCtD
Idarubicin—Dermatitis—Etoposide—sarcoma	1.84e-05	0.000528	CcSEcCtD
Idarubicin—Headache—Etoposide—sarcoma	1.83e-05	0.000525	CcSEcCtD
Idarubicin—Leukopenia—Epirubicin—sarcoma	1.8e-05	0.000515	CcSEcCtD
Idarubicin—Convulsion—Epirubicin—sarcoma	1.74e-05	0.000499	CcSEcCtD
Idarubicin—Nausea—Etoposide—sarcoma	1.74e-05	0.000498	CcSEcCtD
Idarubicin—Anaemia—Doxorubicin—sarcoma	1.72e-05	0.000492	CcSEcCtD
Idarubicin—Chest pain—Epirubicin—sarcoma	1.71e-05	0.00049	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	1.7e-05	0.000486	CcSEcCtD
Idarubicin—Leukopenia—Doxorubicin—sarcoma	1.66e-05	0.000477	CcSEcCtD
Idarubicin—Anaphylactic shock—Epirubicin—sarcoma	1.64e-05	0.00047	CcSEcCtD
Idarubicin—Infection—Epirubicin—sarcoma	1.63e-05	0.000467	CcSEcCtD
Idarubicin—Shock—Epirubicin—sarcoma	1.61e-05	0.000462	CcSEcCtD
Idarubicin—Convulsion—Doxorubicin—sarcoma	1.61e-05	0.000461	CcSEcCtD
Idarubicin—Thrombocytopenia—Epirubicin—sarcoma	1.61e-05	0.00046	CcSEcCtD
Idarubicin—Skin disorder—Epirubicin—sarcoma	1.59e-05	0.000456	CcSEcCtD
Idarubicin—Chest pain—Doxorubicin—sarcoma	1.58e-05	0.000453	CcSEcCtD
Idarubicin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	1.57e-05	0.00045	CcSEcCtD
Idarubicin—Anorexia—Epirubicin—sarcoma	1.56e-05	0.000448	CcSEcCtD
Idarubicin—Anaphylactic shock—Doxorubicin—sarcoma	1.52e-05	0.000434	CcSEcCtD
Idarubicin—Infection—Doxorubicin—sarcoma	1.51e-05	0.000432	CcSEcCtD
Idarubicin—Shock—Doxorubicin—sarcoma	1.49e-05	0.000427	CcSEcCtD
Idarubicin—Thrombocytopenia—Doxorubicin—sarcoma	1.49e-05	0.000425	CcSEcCtD
Idarubicin—Skin disorder—Doxorubicin—sarcoma	1.47e-05	0.000422	CcSEcCtD
Idarubicin—Anorexia—Doxorubicin—sarcoma	1.45e-05	0.000414	CcSEcCtD
Idarubicin—Decreased appetite—Epirubicin—sarcoma	1.43e-05	0.000408	CcSEcCtD
Idarubicin—Gastrointestinal pain—Epirubicin—sarcoma	1.34e-05	0.000384	CcSEcCtD
Idarubicin—Decreased appetite—Doxorubicin—sarcoma	1.32e-05	0.000378	CcSEcCtD
Idarubicin—Urticaria—Epirubicin—sarcoma	1.3e-05	0.000373	CcSEcCtD
Idarubicin—Abdominal pain—Epirubicin—sarcoma	1.3e-05	0.000371	CcSEcCtD
Idarubicin—Body temperature increased—Epirubicin—sarcoma	1.3e-05	0.000371	CcSEcCtD
Idarubicin—Gastrointestinal pain—Doxorubicin—sarcoma	1.24e-05	0.000355	CcSEcCtD
Idarubicin—Hypersensitivity—Epirubicin—sarcoma	1.21e-05	0.000346	CcSEcCtD
Idarubicin—Urticaria—Doxorubicin—sarcoma	1.21e-05	0.000345	CcSEcCtD
Idarubicin—Body temperature increased—Doxorubicin—sarcoma	1.2e-05	0.000343	CcSEcCtD
Idarubicin—Abdominal pain—Doxorubicin—sarcoma	1.2e-05	0.000343	CcSEcCtD
Idarubicin—Diarrhoea—Epirubicin—sarcoma	1.12e-05	0.000321	CcSEcCtD
Idarubicin—Hypersensitivity—Doxorubicin—sarcoma	1.12e-05	0.00032	CcSEcCtD
Idarubicin—Vomiting—Epirubicin—sarcoma	1.04e-05	0.000299	CcSEcCtD
Idarubicin—Diarrhoea—Doxorubicin—sarcoma	1.04e-05	0.000297	CcSEcCtD
Idarubicin—Rash—Epirubicin—sarcoma	1.03e-05	0.000296	CcSEcCtD
Idarubicin—Dermatitis—Epirubicin—sarcoma	1.03e-05	0.000296	CcSEcCtD
Idarubicin—Headache—Epirubicin—sarcoma	1.03e-05	0.000294	CcSEcCtD
Idarubicin—Nausea—Epirubicin—sarcoma	9.74e-06	0.000279	CcSEcCtD
Idarubicin—Vomiting—Doxorubicin—sarcoma	9.65e-06	0.000276	CcSEcCtD
Idarubicin—Rash—Doxorubicin—sarcoma	9.57e-06	0.000274	CcSEcCtD
Idarubicin—Dermatitis—Doxorubicin—sarcoma	9.56e-06	0.000274	CcSEcCtD
Idarubicin—Headache—Doxorubicin—sarcoma	9.51e-06	0.000272	CcSEcCtD
Idarubicin—Nausea—Doxorubicin—sarcoma	9.01e-06	0.000258	CcSEcCtD
